Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal maintenance solution--is neonatalyte safe?

J B Ellis1, C C Lombard, H F Joubert

  • 1Department of Paediatrics, Medical University of Southern Africa, Pretoria.

South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|October 3, 1987
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Desktop based virtual reality to enhance role clarification.

Journal of interprofessional care·2025
Same author

Wolbachia-induced transcription factor GATA4 suppresses ovary-specific genes blastoderm-specific protein 25D and imaginal disc growth factor.

Insect molecular biology·2018
Same author

Surface water sewer misconnections in England and Wales: Pollution sources and impacts.

The Science of the total environment·2015
Same author

The management of urban surface water flood risks: SUDS performance in flood reduction from extreme events.

Water science and technology : a journal of the International Association on Water Pollution Research·2012
Same author

Risk prioritisation of stormwater pollutant sources.

Water research·2011
Same author

Antiviral pandemic risk assessment for urban receiving waters.

Water science and technology : a journal of the International Association on Water Pollution Research·2010
Same journal

SAMA Health Summit Abstracts.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

On behalf of the South African Medical Association (SAMA), The Scientific Committee of the SAMA Health Summit, is pleased to pesent this abstract issue, showcasing the posters and oral presentations delivered at the Summit, which was held from 22-24 May 2026.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

Proceedings of the 2<sup>nd</sup> Data Driven Surgery Conference (DDSC 2025).

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

Clinical practice guidelines for the management of fever and neutropenia in South African children and adolescents with cancer.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

The changing fortunes of the District Health System in SA (1994 - 2020): A retrospective review.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
Same journal

Thomas Micheal Guntram Ignaz Rehle (1951 - 2025).

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
See all related articles

Neonatalyte is a safe intravenous fluid for newborns, preventing electrolyte imbalances like hyperkalemia and hypocalcemia. This study confirms its efficacy in the early neonatal period.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nephrology
  • Clinical Pharmacy

Background:

  • Neonatal intravenous fluid therapy is crucial for managing fluid and electrolyte balance in vulnerable infants.
  • Electrolyte disturbances, such as hyperkalemia and hypocalcemia, are common complications in neonates requiring intensive care.
  • The development of safe and effective intravenous solutions is essential for optimizing neonatal outcomes.

Purpose of the Study:

  • To evaluate the safety and efficacy of Neonatalyte (Sabax) compared to a control solution in neonates requiring intravenous fluids.
  • To assess the impact of Neonatalyte on key biochemical parameters, specifically potassium and calcium levels, in the early neonatal period.

Main Methods:

  • A randomized controlled trial was conducted involving newborns at Ga-Rankuwa Hospital requiring intravenous fluids.

Related Experiment Videos

  • Participants were allocated to receive either Neonatalyte or a control solution from 24 hours of life.
  • Biochemical monitoring (serum electrolytes) was performed every 12 hours for 5 days.

    • Main Results:

    • Neonatalyte administration did not result in hyperkalemia (high potassium levels) in the study population.
    • Neonatalyte did not lead to hypocalcemia (low calcium levels) during the 5-day monitoring period.
    • The study demonstrated biochemical stability in neonates receiving Neonatalyte.

    Conclusions:

    • Neonatalyte is a safe and effective intravenous fluid for neonatal use, as it does not induce hyperkalemia or hypocalcemia.
    • The findings support the use of Neonatalyte in neonatal intensive care units to maintain electrolyte homeostasis.
    • Further research may explore long-term outcomes associated with Neonatalyte administration.